Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Repository Corticotropin Injection in Patients With Severe and Recalcitrant Keratoconjunctivitis Sicca

Trial Profile

Efficacy of Repository Corticotropin Injection in Patients With Severe and Recalcitrant Keratoconjunctivitis Sicca

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2018

At a glance

  • Drugs Corticotropin (Primary)
  • Indications Keratoconjunctivitis sicca
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2018 Planned End Date changed from 1 Apr 2020 to 1 Nov 2018.
    • 12 Dec 2018 Planned primary completion date changed from 1 Apr 2019 to 1 Nov 2018.
    • 12 Dec 2018 Planned initiation date changed from 1 Oct 2018 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top